BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18221872)

  • 1. Synthesis and anticancer activity studies of cyclopamine derivatives.
    Zhang J; Garrossian M; Gardner D; Garrossian A; Chang YT; Kim YK; Chang CW
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1359-63. PubMed ID: 18221872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of cyclopamine using a biomimetic and diastereoselective approach.
    Giannis A; Heretsch P; Sarli V; Stössel A
    Angew Chem Int Ed Engl; 2009; 48(42):7911-4. PubMed ID: 19591183
    [No Abstract]   [Full Text] [Related]  

  • 3. Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists.
    Tremblay MR; Nevalainen M; Nair SJ; Porter JR; Castro AC; Behnke ML; Yu LC; Hagel M; White K; Faia K; Grenier L; Campbell MJ; Cushing J; Woodward CN; Hoyt J; Foley MA; Read MA; Sydor JR; Tong JK; Palombella VJ; McGovern K; Adams J
    J Med Chem; 2008 Nov; 51(21):6646-9. PubMed ID: 18842035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of inhibitors of Hedgehog signaling based on the alkaloid cyclopamine.
    Winkler JD; Isaacs A; Holderbaum L; Tatard V; Dahmane N
    Org Lett; 2009 Jul; 11(13):2824-7. PubMed ID: 19552464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
    Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu LC; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC
    J Med Chem; 2009 Jul; 52(14):4400-18. PubMed ID: 19522463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exo-cyclopamine--a stable and potent inhibitor of hedgehog-signaling.
    Heretsch P; Büttner A; Tzagkaroulaki L; Zahn S; Kirchner B; Giannis A
    Chem Commun (Camb); 2011 Jul; 47(26):7362-4. PubMed ID: 21589966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new cyclopamine glucuronide prodrug with improved kinetics of drug release.
    Renoux B; Legigan T; Bensalma S; Chadéneau C; Muller JM; Papot S
    Org Biomol Chem; 2011 Dec; 9(24):8459-64. PubMed ID: 22042246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomous Hedgehog signalling is undetectable in PC-3 prostate cancer cells.
    McCarthy FR; Brown AJ
    Biochem Biophys Res Commun; 2008 Aug; 373(1):109-12. PubMed ID: 18544338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hedgehog signaling in ovarian cancer.
    Bhattacharya R; Kwon J; Ali B; Wang E; Patra S; Shridhar V; Mukherjee P
    Clin Cancer Res; 2008 Dec; 14(23):7659-66. PubMed ID: 19047091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of extracts and compounds from the rhizomes of Veratrum dahuricum.
    Tang J; Li HL; Shen YH; Jin HZ; Yan SK; Liu RH; Zhang WD
    Phytother Res; 2008 Aug; 22(8):1093-6. PubMed ID: 18570211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the Hedgehog-inhibitor cyclopamine on mice with osteosarcoma pulmonary metastases.
    Warzecha J; Dinges D; Kaszap B; Henrich D; Marzi I; Seebach C
    Int J Mol Med; 2012 Mar; 29(3):423-7. PubMed ID: 22138977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
    Xu FG; Ma QY; Wang Z
    Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total synthesis and anticancer activity of highly potent novel glycolipid derivatives.
    Jung M; Lee Y; Moon HI; Jung Y; Jung H; Oh M
    Eur J Med Chem; 2009 Aug; 44(8):3120-9. PubMed ID: 19342127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of cyclopamine on human non-small cell lung cancer.
    Hu WG; Yao Y
    Saudi Med J; 2010 Nov; 31(11):1274-5. PubMed ID: 21063664
    [No Abstract]   [Full Text] [Related]  

  • 15. Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified.
    Wilson SR; Strand MF; Krapp A; Rise F; Petersen D; Krauss S
    J Pharm Biomed Anal; 2010 Sep; 52(5):707-13. PubMed ID: 20236786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cells.
    Okuhashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2011 Mar; 31(3):893-6. PubMed ID: 21498710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hedgehog signaling reduces the side population in human malignant mesothelioma cell lines.
    Kim HA; Kim MC; Kim NY; Kim Y
    Cancer Gene Ther; 2015 Aug; 22(8):387-95. PubMed ID: 26206198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclopamine, a naturally occurring alkaloid, and its analogues may find wide applications in cancer therapy.
    Ma H; Li HQ; Zhang X
    Curr Top Med Chem; 2013; 13(17):2208-15. PubMed ID: 23978132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One Hundred Faces of Cyclopamine.
    Iovine V; Mori M; Calcaterra A; Berardozzi S; Botta B
    Curr Pharm Des; 2016; 22(12):1658-81. PubMed ID: 26759083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor and antiplatelet activity of alkaloids from veratrum dahuricum.
    Tang J; Li HL; Shen YH; Jin HZ; Yan SK; Liu XH; Zeng HW; Liu RH; Tan YX; Zhang WD
    Phytother Res; 2010 Jun; 24(6):821-6. PubMed ID: 20013819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.